Published in Peptides on June 07, 2016
Xenin-25: Novel Regulator of Insulin Secretion and Beta-cell Function | NCT00949663
Xenin augments duodenal anion secretion via activation of afferent neural pathways. J Pharmacol Exp Ther (2017) 0.75
Bariatric surgery: a systematic review and meta-analysis. JAMA (2004) 23.34
Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med (2004) 17.91
Biology of incretins: GLP-1 and GIP. Gastroenterology (2007) 10.45
Autonomic regulation of islet hormone secretion--implications for health and disease. Diabetologia (2000) 3.03
Effects of arterial versus venous sampling on analysis of glucose kinetics in man. J Appl Physiol (1976) 2.93
Gastric bypass surgery enhances glucagon-like peptide 1-stimulated postprandial insulin secretion in humans. Diabetes (2011) 2.23
Cell and molecular biology of the incretin hormones glucagon-like peptide-I and glucose-dependent insulin releasing polypeptide. Endocr Rev (1995) 2.20
Limited recovery of β-cell function after gastric bypass despite clinical diabetes remission. Diabetes (2013) 2.19
Brain glucagon-like peptide-1 increases insulin secretion and muscle insulin resistance to favor hepatic glycogen storage. J Clin Invest (2005) 2.01
Contribution of endogenous glucagon-like peptide 1 to glucose metabolism after Roux-en-Y gastric bypass. Diabetes (2013) 1.90
Changes in glucose homeostasis after Roux-en-Y gastric bypass surgery for obesity at day three, two months, and one year after surgery: role of gut peptides. J Clin Endocrinol Metab (2011) 1.86
Exaggerated glucagon-like peptide 1 response is important for improved β-cell function and glucose tolerance after Roux-en-Y gastric bypass in patients with type 2 diabetes. Diabetes (2013) 1.66
Mechanisms of improved glycaemic control after Roux-en-Y gastric bypass. Diabetologia (2012) 1.52
Effects of bariatric surgery on glucose homeostasis and type 2 diabetes. Gastroenterology (2012) 1.33
Targeted ablation of glucose-dependent insulinotropic polypeptide-producing cells in transgenic mice reduces obesity and insulin resistance induced by a high fat diet. J Biol Chem (2008) 1.31
Brain uptake of the glucagon-like peptide-1 antagonist exendin(9-39) after intranasal administration. J Pharmacol Exp Ther (2004) 1.23
GLP-1 receptor signaling is not required for reduced body weight after RYGB in rodents. Am J Physiol Regul Integr Comp Physiol (2014) 1.16
Zinc absorption and zinc status are reduced after Roux-en-Y gastric bypass: a randomized study using 2 supplements. Am J Clin Nutr (2011) 1.14
The role of β cell glucagon-like peptide-1 signaling in glucose regulation and response to diabetes drugs. Cell Metab (2014) 1.13
The glucagon-like peptide-1 receptor agonist oxyntomodulin enhances beta-cell function but does not inhibit gastric emptying in mice. Endocrinology (2008) 1.10
The effects of deleting the mouse neurotensin receptor NTR1 on central and peripheral responses to neurotensin. J Pharmacol Exp Ther (2002) 1.09
Peripheral and central administration of xenin and neurotensin suppress food intake in rodents. Obesity (Silver Spring) (2009) 1.06
Xenin-25 potentiates glucose-dependent insulinotropic polypeptide action via a novel cholinergic relay mechanism. J Biol Chem (2010) 1.00
WINSTODEC: a stochastic deconvolution interactive program for physiological and pharmacokinetic systems. Comput Methods Programs Biomed (2002) 1.00
Novel treatments of schizophrenia: targeting the neurotensin system. CNS Neurol Disord Drug Targets (2006) 0.93
Role of neurotensin receptor 1 in the regulation of food intake by neuromedins and neuromedin-related peptides. Neurosci Lett (2009) 0.93
Xenin--a review. Peptides (1998) 0.92
Bipolarity of duodenal enterochromaffin cells in the rat. Cell Tissue Res (1987) 0.92
Localization of xenin-immunoreactive cells in the duodenal mucosa of humans and various mammals. J Histochem Cytochem (2000) 0.92
Novel insulin/GIP co-producing cell lines provide unexpected insights into Gut K-cell function in vivo. J Cell Physiol (2002) 0.92
The gut hormone glucagon-like peptide-1 produced in brain: is this physiologically relevant? Curr Opin Pharmacol (2013) 0.91
Regulated, side-directed secretion of proguanylin from isolated rat colonic mucosa. Endocrinology (1999) 0.91
Identification of xenin, a xenopsin-related peptide, in the human gastric mucosa and its effect on exocrine pancreatic secretion. J Biol Chem (1992) 0.90
Xenin, a gastrointestinal peptide, regulates feeding independent of the melanocortin signaling pathway. Diabetes (2008) 0.87
Xenin reduces feed intake by activating the ventromedial hypothalamus and influences gastrointestinal transit rate in chicks. Behav Brain Res (2007) 0.87
Xenin-25 amplifies GIP-mediated insulin secretion in humans with normal and impaired glucose tolerance but not type 2 diabetes. Diabetes (2012) 0.87
Rapid improvement in diabetes after gastric bypass surgery: is it the diet or surgery? Diabetes Care (2013) 0.87
Xenin--a novel suppressor of food intake in rats. Brain Res (1998) 0.87
Interaction of xenin with the neurotensin receptor of guinea pig enteral smooth muscles. Peptides (2002) 0.86
Xenin-25 increases cytosolic free calcium levels and acetylcholine release from a subset of myenteric neurons. Am J Physiol Gastrointest Liver Physiol (2012) 0.85
Gastroenteropancreatic effects of xenin in the dog. J Pept Res (1997) 0.85
The peptide hormone xenin induces gallbladder contractions in conscious dogs. Neurogastroenterol Motil (2007) 0.85
The heated dorsal hand vein: an alternative arterial sampling site. JPEN J Parenter Enteral Nutr (1989) 0.85
The combination of GIP plus xenin-25 indirectly increases pancreatic polypeptide release in humans with and without type 2 diabetes mellitus. Regul Pept (2013) 0.84
Xenin-25 delays gastric emptying and reduces postprandial glucose levels in humans with and without type 2 diabetes. Am J Physiol Gastrointest Liver Physiol (2013) 0.83
Preserved Insulin Secretory Capacity and Weight Loss Are the Predominant Predictors of Glycemic Control in Patients With Type 2 Diabetes Randomized to Roux-en-Y Gastric Bypass. Diabetes (2015) 0.83
Xenin delays gastric emptying rate and activates the brainstem in mice. Neurosci Lett (2010) 0.83
Current understanding of guanylin peptides actions. ISRN Nephrol (2013) 0.82
Degradation, insulin secretion, glucose-lowering and GIP additive actions of a palmitate-derivatised analogue of xenin-25. Biochem Pharmacol (2012) 0.82
Guanylin and related peptides. J Physiol Pharmacol (2001) 0.81
Chylomicron formation and secretion is required for lipid-stimulated release of incretins GLP-1 and GIP. Lipids (2012) 0.80
Release of guanylin immunoreactivity from the isolated vascularly perfused rat colon. Endocrinology (2000) 0.79
Inter-organ communication and regulation of beta cell function. Diabetologia (2016) 0.76